person · Reporting owner

Carestio Daniel A

Disclosed activity across 2 companies

Tapewire entity: 40499
SEC CIK: 0001651806

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
STERIS plcSTE · Entity 3228	Director · President and CEO	June 04, 2026	June 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

STERIS plc

Report date June 04, 2026 · Filed June 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	68,075	Reported balance After 2026-06-04 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-06-04 · Tax withholding · Disposed 1,889 · Balance 68,075 F1: 1,889 shares were withheld from the 4,283 restricted shares that vested on June 4, 2026. These 1,889 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 4, 2026.
Ordinary SharesSEC Table I · non-derivative	Direct	65,021	Reported balance After 2026-06-04 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2026-06-04 · Sale · Disposed 3,054 · Balance 65,021
Ordinary SharesSEC Table I · non-derivative	Direct	63,647	Reported balance After 2026-06-05 transaction · row 3 Account or security details depend on footnotes; rows are not merged. 1 source row Row 3 · 2026-06-05 · Sale · Disposed 1,374 · Balance 63,647 F2: As of June 8, 2026, 39,893 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,912 on June 2, 2027; 5,937 on June 3, 2027; 4,283 on June 4, 2027; 7,912 on June 2, 2028; 5,937 on June 5, 2028 and 7,912 on June 4, 2029.

Filing footnotes · ownership attribution and instrument terms

F1: 1,889 shares were withheld from the 4,283 restricted shares that vested on June 4, 2026. These 1,889 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 4, 2026.

F2: As of June 8, 2026, 39,893 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,912 on June 2, 2027; 5,937 on June 3, 2027; 4,283 on June 4, 2027; 7,912 on June 2, 2028; 5,937 on June 5, 2028 and 7,912 on June 4, 2029.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

STERIS plc

Report date March 28, 2019 · Filed March 28, 2019

Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Ordinary Shares, 10 pence par valueSEC Table I · non-derivative	Direct	Reported balance After 2019-03-28 transaction · row 1 1 source row Row 1 · 2019-03-28 · Disposition to issuer · Disposed 20,460 · Balance 0 F1: 20,460 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022 and 1,748 on October 3, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30	Direct	Reported balance After 2019-03-28 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2019-03-28 · Disposition to issuer · Disposed 7,000 · Balance 0 F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.98 · Expires 2025-08-10	Direct	Reported balance After 2019-03-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-03-28 · Disposition to issuer · Disposed 8,000 · Balance 0 F4: This option will become exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 8,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01	Direct	Reported balance After 2019-03-28 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-03-28 · Disposition to issuer · Disposed 15,000 · Balance 0 F5: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30	Direct	Reported balance After 2019-03-28 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2019-03-28 · Disposition to issuer · Disposed 18,000 · Balance 0 F6: This option becomes exercisable as follows: 4,500 on May 30, 2018; 4,500 on May 30, 2019; 4,500 on June 1, 2020 and 4,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 18,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31	Direct	Reported balance After 2019-03-28 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2019-03-28 · Disposition to issuer · Disposed 29,864 · Balance 0 F7: This option becomes exercisable as follows: 7,466 on May 31, 2019; 7,466 on June 1, 2020; 7,466 on June 1, 2021 and 7,466 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 29,864 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $125.58 · Expires 2028-10-01	Direct	Reported balance After 2019-03-28 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2019-03-28 · Disposition to issuer · Disposed 9,468 · Balance 0 F8: This option becomes exercisable as follows: 2,367 shares on October 1, 2019; 2,367 shares on October 1, 2020; 2,367 shares on October 1, 2021 and 2,367 shares on October 3, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 9,468 ordinary shares of STERIS for $125.58 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

Filing footnotes · ownership attribution and instrument terms

F1: 20,460 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022 and 1,748 on October 3, 2022.

F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.

F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F4: This option will become exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 8,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F5: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F6: This option becomes exercisable as follows: 4,500 on May 30, 2018; 4,500 on May 30, 2019; 4,500 on June 1, 2020 and 4,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 18,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F7: This option becomes exercisable as follows: 7,466 on May 31, 2019; 7,466 on June 1, 2020; 7,466 on June 1, 2021 and 7,466 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 29,864 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F8: This option becomes exercisable as follows: 2,367 shares on October 1, 2019; 2,367 shares on October 1, 2020; 2,367 shares on October 1, 2021 and 2,367 shares on October 3, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 9,468 ordinary shares of STERIS for $125.58 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 18, 2020 Filed Sep 21, 2020 20:38 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	14,794	$175.51	$2,596,494.94	Disclosure SEC source: 0001209191-20-051291 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,520 F2 · shares: This exercise of stock options and sale of a total of 14,872 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $175.02 to $176.00 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
September 18, 2020 Filed Sep 21, 2020 20:38 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	15,000	$69.72	$1,045,800.00	Disclosure SEC source: 0001209191-20-051291 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
September 15, 2020 Filed Sep 17, 2020 20:33 UTC	STERIS plc STE · Entity 3228	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	8,000	$0.00 Strike: $67.98	$0.00	Disclosure SEC source: 0001209191-20-050909 · doc4.xml · derivative · entry 5 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,000 shares Expires 2025-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option to purchase 8,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS"), in exchange for an option to purchase 8,000 Old STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document
September 15, 2020 Filed Sep 17, 2020 20:33 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	211	$170.31	$35,935.41	Disclosure SEC source: 0001209191-20-050909 · doc4.xml · nonDerivative · entry 4 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,314 F6 · shares: This exercise of stock options and sale of a total of 211 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F7 · price: Price reflects a weighted average sale price for multiple transactions ranging from $170.2650 to $170.34 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
September 15, 2020 Filed Sep 17, 2020 20:33 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	6,750	$169.66	$1,145,205.00	Disclosure SEC source: 0001209191-20-050909 · doc4.xml · nonDerivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,525 F4 · shares: This exercise of stock options and sale of a total of 6,750 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $169.22 to $170.2150 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
September 15, 2020 Filed Sep 17, 2020 20:33 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	1,039	$168.94	$175,528.66	Disclosure SEC source: 0001209191-20-050909 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,275 F2 · shares: This exercise of stock options and sale of a total of 1,039 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $168.17 to $169.17 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
September 15, 2020 Filed Sep 17, 2020 20:33 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	8,000	$67.98	$543,840.00	Disclosure SEC source: 0001209191-20-050909 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
June 01, 2020 Filed Jun 3, 2020 20:29 UTC	STERIS plc STE · Entity 3228	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	26,776	$0.00 Strike: $182.22	$0.00	Disclosure SEC source: 0001209191-20-034025 · doc4.xml · derivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,776 Underlying: Ordinary Shares · 26,776 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option becomes exercisable as follows: 6,694 on June 1, 2021, 6,694 on June 1, 2022, 6,694 on June 1, 2023 and 6,694 on June 3, 2024. Read SEC document
June 01, 2020 Filed Jun 3, 2020 20:29 UTC	STERIS plc STE · Entity 3228	Disposition to issuerOrdinary Shares	747	$165.65	$123,740.55	Disclosure SEC source: 0001209191-20-034025 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,314 F2 · shares: 747 shares were withheld from the 2,500 restricted shares that vested on June 1, 2020. These 747 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,500 shares were awarded to Mr. Carestio on June 1, 2016. These vested shares were valued at the NYSE closing market price on June 1, 2020. F3 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
June 01, 2020 Filed Jun 3, 2020 20:29 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	4,432	$0.00	$0.00	Disclosure SEC source: 0001209191-20-034025 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,061 F1 · shares: All 4,432 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
October 01, 2019 Filed Oct 2, 2019 20:31 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	1,346	$140.62	$189,274.52	Disclosure SEC source: 0001209191-19-051708 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,629 F1 · balance_after: 17,468 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; and 5,008 on May 31, 2023. Read SEC document
August 07, 2019 Filed Aug 8, 2019 20:45 UTC	STERIS plc STE · Entity 3228	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	7,000	$0.00 Strike: $53.52	$0.00	Disclosure SEC source: 0001209191-19-045130 · doc4.xml · derivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,000 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document
August 07, 2019 Filed Aug 8, 2019 20:45 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	7,000	$149.27	$1,044,890.00	Disclosure SEC source: 0001209191-19-045130 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,975 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $148.73 to $149.72 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document
August 07, 2019 Filed Aug 8, 2019 20:45 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	7,000	$53.52	$374,640.00	Disclosure SEC source: 0001209191-19-045130 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 20,468 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; and 5,008 on May 31, 2023. Read SEC document
May 31, 2019 Filed Jun 3, 2019 20:36 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	28,868	$0.00 Strike: $147.05	$0.00	Disclosure SEC source: 0001209191-19-033939 · doc4.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,868 Underlying: Ordinary Shares · 28,868 shares Expires 2029-05-31 F3 · derivative.exercise_date: This option becomes exercisable as follows: 7,217 on June 1, 2020; 7,217 on June 1, 2021; 7,217 on May 31, 2022 and 7,217 on May 31, 2023. Read SEC document
May 31, 2019 Filed Jun 3, 2019 20:36 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	5,008	$0.00	$0.00	Disclosure SEC source: 0001209191-19-033939 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,975 F1 · shares: All 5,008 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,008 on May 31, 2023. F2 · balance_after: 20,468 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; and 5,008 on May 31, 2023. Read SEC document
May 28, 2019 Filed May 30, 2019 20:30 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	1,493	$133.92	$199,942.56	Disclosure SEC source: 0001209191-19-033437 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,967 F1 · shares: 1,493 shares were withheld from the 5,000 restricted shares that vested on May 28, 2019. These 1,493 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 5,000 ordinary shares were awarded to Mr. Carestio on August 10, 2015. These vested shares were valued at the NYSE closing market price on May 28, 2019. F2 · balance_after: 15,460 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022 and 1,748 on October 3, 2022. Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:59 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	9,468	Not disclosed Strike: $125.58	Not disclosed	Disclosure SEC source: 0001209191-19-021598 · doc4.xml · derivative · entry 7 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,468 Underlying: Ordinary Shares · 9,468 shares Expires 2028-10-01 F8 · price: This option becomes exercisable as follows: 2,367 shares on October 1, 2019; 2,367 shares on October 1, 2020; 2,367 shares on October 1, 2021 and 2,367 shares on October 3, 2022. This option was received under the Scheme in exchange for an option to purchase 9,468 STERIS ordinary shares for $125.58 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 2,367 shares on October 1, 2019; 2,367 shares on October 1, 2020; 2,367 shares on October 1, 2021 and 2,367 shares on October 3, 2022. This option was received under the Scheme in exchange for an option to purchase 9,468 STERIS ordinary shares for $125.58 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:59 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	29,864	Not disclosed Strike: $114.22	Not disclosed	Disclosure SEC source: 0001209191-19-021598 · doc4.xml · derivative · entry 6 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,864 Underlying: Ordinary Shares · 29,864 shares Expires 2028-05-31 F7 · price: This option becomes exercisable as follows: 7,466 on May 31, 2019; 7,466 on June 1, 2020; 7,466 on June 1, 2021 and 7,466 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 29,864 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option becomes exercisable as follows: 7,466 on May 31, 2019; 7,466 on June 1, 2020; 7,466 on June 1, 2021 and 7,466 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 29,864 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:59 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	18,000	Not disclosed Strike: $77.07	Not disclosed	Disclosure SEC source: 0001209191-19-021598 · doc4.xml · derivative · entry 5 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Ordinary Shares · 18,000 shares Expires 2027-05-30 F6 · price: This option becomes exercisable as follows: 4,500 on May 30, 2018; 4,500 on May 30, 2019; 4,500 on June 1, 2020 and 4,500 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 18,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 4,500 on May 30, 2018; 4,500 on May 30, 2019; 4,500 on June 1, 2020 and 4,500 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 18,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:59 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	15,000	Not disclosed Strike: $69.72	Not disclosed	Disclosure SEC source: 0001209191-19-021598 · doc4.xml · derivative · entry 4 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2026-06-01 F5 · price: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F5 · derivative.exercise_date: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:59 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	8,000	Not disclosed Strike: $67.98	Not disclosed	Disclosure SEC source: 0001209191-19-021598 · doc4.xml · derivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Ordinary Shares · 8,000 shares Expires 2025-08-10 F4 · price: This option becomes exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 8,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option becomes exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 8,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:59 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	7,000	Not disclosed Strike: $53.52	Not disclosed	Disclosure SEC source: 0001209191-19-021598 · doc4.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Ordinary Shares · 7,000 shares Expires 2024-05-30 F3 · price: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option F3 · derivative.exercise_date: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:59 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	20,460	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-021598 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,460 F1 · shares: 20,460 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022 and 1,748 on October 3, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F1 · balance_after: 20,460 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022 and 1,748 on October 3, 2022. Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:42 UTC	STERIS plc STE · Entity 158792	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	9,468	Not disclosed Strike: $125.58	Not disclosed	Disclosure SEC source: 0001209191-19-021556 · doc4.xml · derivative · entry 7 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,468 shares Expires 2028-10-01 F8 · price: This option becomes exercisable as follows: 2,367 shares on October 1, 2019; 2,367 shares on October 1, 2020; 2,367 shares on October 1, 2021 and 2,367 shares on October 3, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 9,468 ordinary shares of STERIS for $125.58 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 2,367 shares on October 1, 2019; 2,367 shares on October 1, 2020; 2,367 shares on October 1, 2021 and 2,367 shares on October 3, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 9,468 ordinary shares of STERIS for $125.58 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:42 UTC	STERIS plc STE · Entity 158792	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	29,864	Not disclosed Strike: $114.22	Not disclosed	Disclosure SEC source: 0001209191-19-021556 · doc4.xml · derivative · entry 6 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 29,864 shares Expires 2028-05-31 F7 · price: This option becomes exercisable as follows: 7,466 on May 31, 2019; 7,466 on June 1, 2020; 7,466 on June 1, 2021 and 7,466 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 29,864 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F7 · derivative.exercise_date: This option becomes exercisable as follows: 7,466 on May 31, 2019; 7,466 on June 1, 2020; 7,466 on June 1, 2021 and 7,466 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 29,864 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:42 UTC	STERIS plc STE · Entity 158792	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	18,000	Not disclosed Strike: $77.07	Not disclosed	Disclosure SEC source: 0001209191-19-021556 · doc4.xml · derivative · entry 5 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 18,000 shares Expires 2027-05-30 F6 · price: This option becomes exercisable as follows: 4,500 on May 30, 2018; 4,500 on May 30, 2019; 4,500 on June 1, 2020 and 4,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 18,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 4,500 on May 30, 2018; 4,500 on May 30, 2019; 4,500 on June 1, 2020 and 4,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 18,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:42 UTC	STERIS plc STE · Entity 158792	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	15,000	Not disclosed Strike: $69.72	Not disclosed	Disclosure SEC source: 0001209191-19-021556 · doc4.xml · derivative · entry 4 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-06-01 F5 · price: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F5 · derivative.exercise_date: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:42 UTC	STERIS plc STE · Entity 158792	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	8,000	Not disclosed Strike: $67.98	Not disclosed	Disclosure SEC source: 0001209191-19-021556 · doc4.xml · derivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,000 shares Expires 2025-08-10 F4 · price: This option will become exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 8,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F4 · derivative.exercise_date: This option will become exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 8,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:42 UTC	STERIS plc STE · Entity 158792	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	7,000	Not disclosed Strike: $53.52	Not disclosed	Disclosure SEC source: 0001209191-19-021556 · doc4.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,000 shares Expires 2024-05-30 F3 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F3 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:42 UTC	STERIS plc STE · Entity 158792	Disposition to issuerOrdinary Shares, 10 pence par value	20,460	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-021556 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: 20,460 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022 and 1,748 on October 3, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document
October 01, 2018 Filed Oct 3, 2018 16:37 UTC	STERIS plc STE · Entity 158792	GrantEmployee Stock Option (right to buy) · Derivative	9,468	$0.00 Strike: $125.58	$0.00	Disclosure SEC source: 0001209191-18-053834 · doc4.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,468 Underlying: Ordinary Shares · 9,468 shares Expires 2028-10-01 F3 · derivative.exercise_date: This option becomes exercisable as follows: 2,367 shares on October 1, 2019; 2,367 shares on October 1, 2020; 2,367 shares on October 1, 2021 and 2,367 shares on October 3, 2022. Read SEC document
October 01, 2018 Filed Oct 3, 2018 16:37 UTC	STERIS plc STE · Entity 158792	GrantOrdinary Shares, 10 pence par value	1,748	$0.00	$0.00	Disclosure SEC source: 0001209191-18-053834 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,460 F1 · shares: All 1,748 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,748 on October 3, 2022. F2 · balance_after: 20,460 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022 and 1,748 on October 3, 2022. Read SEC document
June 07, 2018 Filed Jun 7, 2018 16:50 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 10 pence par value	2,806	$105.90	$297,155.40	Disclosure SEC source: 0001209191-18-036385 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP, Sterilizat & Disinfect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,712 F1 · shares: This sale of a total of 2,806 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 11, 2017. F2 · balance_after: 18,712 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; and 2,712 on May 31, 2022. Read SEC document
May 31, 2018 Filed Jun 1, 2018 16:44 UTC	STERIS plc STE · Entity 158792	GrantEmployee Stock Option (right to buy) · Derivative	29,864	$0.00 Strike: $114.22	$0.00	Disclosure SEC source: 0001209191-18-034706 · doc4.xml · derivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr VP, Sterilizat & Disinfect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,864 Underlying: Ordinary Shares · 29,864 shares Expires 2028-05-31 F3 · derivative.exercise_date: This option becomes exercisable as follows: 7,466 on May 31, 2019; 7,466 on June 1, 2020; 7,466 on June 1, 2021 and 7,466 on May 31, 2022. Read SEC document
May 31, 2018 Filed Jun 1, 2018 16:44 UTC	STERIS plc STE · Entity 158792	GrantOrdinary Shares, 10 pence par value	2,712	$0.00	$0.00	Disclosure SEC source: 0001209191-18-034706 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP, Sterilizat & Disinfect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,518 F1 · shares: All 2,712 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 2,712 on May 31, 2022. F2 · balance_after: 18,712 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; and 2,712 on May 31, 2022. Read SEC document
May 30, 2018 Filed Jun 1, 2018 16:44 UTC	STERIS plc STE · Entity 158792	Tax withholdingOrdinary Shares, 10 pence par value	1,194	$104.57	$124,856.58	Disclosure SEC source: 0001209191-18-034706 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP, Sterilizat & Disinfect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,806 Read SEC document
June 13, 2017 Filed Jun 14, 2017 16:29 UTC	STERIS plc STE · Entity 158792	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	2,530	$0.00 Strike: $45.34	$0.00	Disclosure SEC source: 0001209191-17-039828 · doc4.xml · derivative · entry 4 Carestio Daniel A · CIK 0001651806 · Sr. V. P. STE AST & Life Sci 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,530 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: This exercise and sale of a total of 2,530 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 16, 2016. F5 · derivative.exercise_date: This option became exercisable as follows: 2,530 on May 31, 2014; 2,530 on May 31, 2015; 2,530 on May 31, 2016 and 2,530 on May 31, 2017. This option to purchase 10,120 STERIS plc shares was received in the Merger in exchange for an option to purchase 10,120 STERIS Corporation common shares for $45.34 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document
June 13, 2017 Filed Jun 14, 2017 16:29 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 10 pence par value	2,530	$80.46	$203,563.80	Disclosure SEC source: 0001209191-17-039828 · doc4.xml · nonDerivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr. V. P. STE AST & Life Sci 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F3 · kind: This exercise and sale of a total of 2,530 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 16, 2016. F4 · price: This represents the average sales price of the 2,530 shares sold in the open market. The actual sales prices ranged from $80.00 per share to $80.78 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of the 15 sales prices. F2 · balance_after: 20,000 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on May 30, 2018; 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019 and 5,500 on June 1, 2021. Read SEC document
June 13, 2017 Filed Jun 14, 2017 16:29 UTC	STERIS plc STE · Entity 158792	Exercise / conversionOrdinary Shares, 10 pence par value	2,530	$45.34	$114,710.20	Disclosure SEC source: 0001209191-17-039828 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr. V. P. STE AST & Life Sci 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: This exercise and sale of a total of 2,530 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 16, 2016. Read SEC document
June 12, 2017 Filed Jun 14, 2017 16:29 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 10 pence par value	2,215	$79.64	$176,402.60	Disclosure SEC source: 0001209191-17-039828 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr. V. P. STE AST & Life Sci 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · kind: This sale of a total of 2,215 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 16, 2016. F2 · balance_after: 20,000 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on May 30, 2018; 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019 and 5,500 on June 1, 2021. Read SEC document
May 31, 2017 Filed Jun 1, 2017 16:37 UTC	STERIS plc STE · Entity 158792	Tax withholdingOrdinary Shares, 10 pence par value	1,085	$77.56	$84,152.60	Disclosure SEC source: 0001209191-17-036802 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr. V. P. STE AST & Life Sci 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,215 F2 · shares: 1,085 shares were withheld from the 3,300 restricted shares that vested on May 31, 2017. These 1,085 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 3,300 ordinary shares were awarded to Mr. Carestio on May 31, 2013. These vested shares were valued at the NYSE closing market price on May 31, 2017. F3 · balance_after: 20,000 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on May 30, 2018; 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019 and 5,500 on June 1, 2021. Read SEC document
May 30, 2017 Filed Jun 1, 2017 16:37 UTC	STERIS plc STE · Entity 158792	GrantEmployee Stock Option (right to buy) · Derivative	18,000	$0.00 Strike: $77.07	$0.00	Disclosure SEC source: 0001209191-17-036802 · doc4.xml · derivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr. V. P. STE AST & Life Sci 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Ordinary Shares · 18,000 shares Expires 2027-05-30 F4 · derivative.exercise_date: This option becomes exercisable as follows: 4,500 on May 30, 2018; 4,500 on May 30, 2019; 4,500 on June 1, 2020 and 4,500 on June 1, 2021. Read SEC document
May 30, 2017 Filed Jun 1, 2017 16:37 UTC	STERIS plc STE · Entity 158792	GrantOrdinary Shares, 10 pence par value	5,500	$0.00	$0.00	Disclosure SEC source: 0001209191-17-036802 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr. V. P. STE AST & Life Sci 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,300 F1 · shares: All 5,500 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021. Read SEC document
May 03, 2017 Filed May 5, 2017 16:38 UTC	STERIS plc STE · Entity 158792	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	7,590	$0.00 Strike: $45.34	$0.00	Disclosure SEC source: 0001209191-17-030352 · doc4.xml · derivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr. V. P. STE AST & Life Sci 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,530 Underlying: Ordinary Shares · 7,590 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option became or will become exercisable as follows: 2,530 on May 31, 2014; 2,530 on May 31, 2015; 2,530 on May 31, 2016 and 2,530 on May 31, 2017. This option to purchase 10,120 STERIS plc shares was received in the Merger in exchange for an option to purchase 10,120 STERIS Corporation common shares for $45.34 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document
May 03, 2017 Filed May 5, 2017 16:38 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 10 pence par value	7,590	$75.17	$570,516.77	Disclosure SEC source: 0001209191-17-030352 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr. V. P. STE AST & Life Sci 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,800 F2 · price: This represents the average sales price of the 7,590 shares sold in the open market. The actual sales prices ranged from $75.00 per share to $75.60 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of the 31 sales prices. F3 · balance_after: 17,800 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,300 on May 31, 2017; 4,000 on May 30, 2018, 5,000 on May 28, 2019, 3,000 on October 1, 2019 and 2,500 on June 1, 2020. Read SEC document
May 03, 2017 Filed May 5, 2017 16:38 UTC	STERIS plc STE · Entity 158792	Exercise / conversionOrdinary Shares, 10 pence par value	7,590	$45.34	$344,130.60	Disclosure SEC source: 0001209191-17-030352 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr. V. P. STE AST & Life Sci 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 7,590 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 16, 2016. Read SEC document
December 08, 2016 Filed Dec 9, 2016 16:41 UTC	STERIS plc STE · Entity 158792	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	2,225	Not disclosed Strike: $29.94	Not disclosed	Disclosure SEC source: 0001209191-16-154432 · doc4.xml · derivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr. V. P., Isomedix & Life Sci 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares, 0.10 · 2,225 shares Expires 2022-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: This option is fully exercisable. This option was received in the merger in exchange for an option to purchase 2,225 STERIS common shares for $29.94 per share, subject to the same terms and conditions as the original STERIS stock option. F3 · derivative.exercise_date: This option is fully exercisable. This option was received in the merger in exchange for an option to purchase 2,225 STERIS common shares for $29.94 per share, subject to the same terms and conditions as the original STERIS stock option. Read SEC document
December 08, 2016 Filed Dec 9, 2016 16:41 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 0.10 par value	2,225	$67.54	$150,272.72	Disclosure SEC source: 0001209191-16-154432 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr. V. P., Isomedix & Life Sci 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,800 F1 · price: This represents the average sales price of the 2,225 shares sold in the open market. The actual sales prices ranged from $67.50 per share to $67.72 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of these eight sales prices. F2 · balance_after: 17,800 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,300 on May 31, 2017; 4,000 on May 30, 2018, 5,000 on May 28, 2019, 3,000 on October 1, 2019 and 2,500 on June 1, 2020. Read SEC document
December 08, 2016 Filed Dec 9, 2016 16:41 UTC	STERIS plc STE · Entity 158792	Exercise / conversionOrdinary Shares, 0.10 par value	2,225	$29.94	$66,616.50	Disclosure SEC source: 0001209191-16-154432 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr. V. P., Isomedix & Life Sci 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.